Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
3.950
-0.120 (-2.95%)
Aug 28, 2025, 10:07 AM - Market open
Microbot Medical Market Cap
Microbot Medical has a market cap or net worth of $179.91 million as of August 28, 2025. Its market cap has increased by 1,185.05% in one year.
Market Cap
179.91M
Enterprise Value
152.85M
1-Year Change
1,185.05%
Ranking
Category
Stock Price
$3.95
Market Cap Chart
Since December 1, 1998, Microbot Medical's market cap has increased from $25.90M to $179.91M, an increase of 594.62%. That is a compound annual growth rate of 7.51%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 27, 2025 | 185.40M | 875.79% |
Dec 31, 2024 | 19.00M | -1.04% |
Dec 29, 2023 | 19.20M | -19.33% |
Dec 30, 2022 | 23.80M | -55.35% |
Dec 31, 2021 | 53.30M | 8.78% |
Dec 31, 2020 | 49.00M | 11.87% |
Dec 31, 2019 | 43.80M | 758.82% |
Dec 31, 2018 | 5.10M | -87.06% |
Dec 29, 2017 | 39.40M | 258.18% |
Dec 30, 2016 | 11.00M | -75.72% |
Dec 31, 2015 | 45.30M | -29.77% |
Dec 31, 2014 | 64.50M | -4.59% |
Dec 31, 2013 | 67.60M | 10.82% |
Dec 31, 2012 | 61.00M | 416.95% |
Dec 30, 2011 | 11.80M | -91.40% |
Dec 31, 2010 | 137.20M | -7.98% |
Dec 31, 2009 | 149.10M | 35.05% |
Dec 31, 2008 | 110.40M | -8.76% |
Dec 31, 2007 | 121.00M | -41.32% |
Dec 29, 2006 | 206.20M | -7.62% |
Dec 30, 2005 | 223.20M | -2.75% |
Dec 31, 2004 | 229.50M | 242.54% |
Dec 31, 2003 | 67.00M | 130.24% |
Dec 31, 2002 | 29.10M | -64.47% |
Dec 31, 2001 | 81.90M | 56.90% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 624.22B |
Johnson & Johnson | 429.67B |
AbbVie | 366.65B |
UnitedHealth Group | 276.10B |
Novo Nordisk | 255.49B |
AstraZeneca | 251.25B |
Novartis AG | 244.09B |
Abbott Laboratories | 229.51B |